共 50 条
- [31] Interstitial High Dose Rate (HDR) Brachytherapy as Monotherapy for Early Stage Prostate Cancer: Median 8 Year Results in 317 Patients AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (02): : 207 - 208
- [34] Interstitial High Dose Rate (HDR) Brachytherapy as Monotherapy for Early-stage Prostate Cancer: Median 8 Year Results in 321 Patients INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S14 - S14
- [36] Interstitial high dose rate (HDR) brachtherapy as monotherapy for early stage prostate cancer: A report of 206 cases INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S329 - S329
- [38] Previous Transurethral Resection of the Prostate (TURP) is Not a Contraindication for Interstitial High Dose Rate (HDR) Brachytherapy for Prostate Cancer AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (02): : 205 - 205
- [39] Previous Transurethral Resection of the Prostate (TURP) is Not a Contraindication for Interstitial High Dose Rate (HDR) Brachytherapy for Prostate Cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S318 - S318
- [40] Previous Transurethral Resection of the Prostate (TURP) is not a Contraindication for Interstitial High Dose Rate (HDR) Brachytherapy for Prostate Cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S371 - S371